After she was diagnosed with breast cancer nearly two decades ago at the age of 39, a form of personalized medicine offered a treatment for Wendy Harris.
Fighting an aggressive tumor, she participated in a clinical trial for Herceptin — a new treatment at the time that was suited for her type of cancer.
"It saved my life," Harris said. "It's now a standard of care, but at the time, that was brand new — kind of the first foray into personalized medicine and attacking each cancer uniquely for…
